Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Paneni

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Cardiovascular Diabetology|November 14, 2023
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathySarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, et al.
Kidney International|May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease riskEva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
Cardiovascular Research|February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathwaysAlexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
Circulation|February 16, 2013
Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunctionFrancesco Paneni, Elena Osto, Sarah Costantino, et al.
International Journal of Cardiology|April 7, 2018
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injuryCandela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|September 15, 2020
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic systemLuca Liberale, Alexander Akhmedov, Nikolaos I Vlachogiannis, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|May 14, 2020
Deletion of fibroblast activation protein provides atheroprotectionSokrates Stein, Julien Weber, Stefanie Nusser-Stein, et al.
Cardiovascular Diabetology|July 3, 2025
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertensionEra Gorica, Jacopo Spezzini, Iliana Papadopoulou, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Cardiovascular Research|August 22, 2022
SGLT-2 inhibition by empagliflozin has no effect on experimental arterial thrombosis in a murine model of low-grade inflammationLuca Liberale, Simon Kraler, Yustina M Puspitasari, et al.
Cardiovascular Diabetology|November 14, 2023
Treatment with recombinant Sirt1 rewires the cardiac lipidome and rescues diabetes-related metabolic cardiomyopathySarah Costantino, Alessandro Mengozzi, Srividya Velagapudi, et al.
Kidney International|May 9, 2018
The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease riskEva-Maria Pastor-Arroyo, Nicole Gehring, Christiane Krudewig, et al.
Cardiovascular Research|February 16, 2017
Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathwaysAlexander Akhmedov, Giovanni G Camici, Martin F Reiner, et al.
Circulation|February 16, 2013
Deletion of the activated protein-1 transcription factor JunD induces oxidative stress and accelerates age-related endothelial dysfunctionFrancesco Paneni, Elena Osto, Sarah Costantino, et al.
International Journal of Cardiology|April 7, 2018
Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injuryCandela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|September 15, 2020
Sirtuin 5 promotes arterial thrombosis by blunting the fibrinolytic systemLuca Liberale, Alexander Akhmedov, Nikolaos I Vlachogiannis, et al.
International Journal of Cardiology|July 16, 2018
Corrigendum to 'Sirtuin 5 as a novel target to blunt blood-brain barrier damage induced by cerebral ischemia/reperfusion injury' [Int. J. Cardiol. 260 (2018) 148-155]Candela Diaz-Cañestro, Mario Merlini, Nicole R Bonetti, et al.
Cardiovascular Research|May 14, 2020
Deletion of fibroblast activation protein provides atheroprotectionSokrates Stein, Julien Weber, Stefanie Nusser-Stein, et al.
Cardiovascular Diabetology|July 3, 2025
Single nuclei RNA-sequencing unveils alveolar macrophages as drivers of endothelial damage in obese HFpEF-related pulmonary hypertensionEra Gorica, Jacopo Spezzini, Iliana Papadopoulou, et al.
Pageof 22